Gökdeniz Gür Appointed as CFO of Sanovel
Sanovel, one of the leading companies in the Turkish pharmaceutical sector, continues to strengthen its senior management team in line with its growth, globalization and sustainability targets. As part of this effort, Gökdeniz Gür, who has approximately 30 years of experience in financial management, strategic planning, corporate efficiency and internal audit, took up the position of Chief Financial Officer (CFO) at Sanovel as of June 2026.
Sanovel, one of Turkey's leading pharmaceutical companies, continues to strengthen its senior management team in line with its growth, globalization and sustainability objectives. In this context, Gökdeniz Gür, who has approximately 30 years of experience in financial management, strategic planning, corporate efficiency and internal audit, took office as Chief Financial Officer (CFO) at Sanovel as of June 2026.
Gökdeniz Gür completed his undergraduate education at Bilkent University Department of Economics. He started his career in 1995 at Garanti Bank. He subsequently worked in audit and consulting at PwC, contributing to numerous strategic finance and transformation projects.
Throughout his professional career, Gür has held senior management positions in various sectors; he served as CFO at Turcotel, a TUI AG subsidiary, and Akfen GYO, Strategic Finance Consultant at Hidromek, and Director of Strategic Planning at Beyçelik Holding. Most recently, between 2019-2025, he worked as Deputy General Manager responsible for Corporate Efficiency and Internal Audit at Florence Nightingale Hospitals, leading numerous important projects in financial performance management, process optimization, reporting systems and internal audit.
Sanovel believes that Gökdeniz Gür's experience in financial management and strategic transformation will make significant contributions to the company's sustainable growth objectives and vision of strengthening its position in international markets.
About Sanovel
Founded in 1983 by Pharmacist Erol Toksöz, Sanovel is among the leading companies in the Turkish pharmaceutical sector. The company operates with a strong portfolio of more than 60 brands and over 180 products, with an annual production capacity of 200 million boxes.
Sanovel, which holds European Union cGMP (Good Manufacturing Practice) certification and US Food and Drug Administration (FDA) approval, maintains its pioneering position in the sector with its strong R&D infrastructure and achievements in patents and intellectual property. The company, which delivers its products to more than 50 countries across 5 continents, continues to strengthen its presence in international markets through export activities.
Sanovel, which brings the first equivalent product to market in many therapeutic areas, continues to create value for the health of societies with approximately 2,000 employees and to contribute to the Turkish pharmaceutical sector.
Gallery
